Bicocca Open Archive

Logo unimib boa
BARDINI, MICHELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.340
EU - Europa 2.638
AS - Asia 2.329
SA - Sud America 392
Continente sconosciuto - Info sul continente non disponibili 216
AF - Africa 52
OC - Oceania 1
Totale 10.968
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.046
IT - Italia 905
SG - Singapore 793
CN - Cina 609
RU - Federazione Russa 304
HK - Hong Kong 290
DE - Germania 282
BR - Brasile 268
VN - Vietnam 240
SE - Svezia 238
IE - Irlanda 227
CA - Canada 217
UA - Ucraina 142
GB - Regno Unito 122
IN - India 80
FR - Francia 78
ES - Italia 68
FI - Finlandia 61
BD - Bangladesh 52
NL - Olanda 52
AT - Austria 41
AR - Argentina 40
KR - Corea 37
EC - Ecuador 34
ID - Indonesia 32
IQ - Iraq 31
MX - Messico 24
TR - Turchia 23
SA - Arabia Saudita 21
DK - Danimarca 20
PL - Polonia 20
BE - Belgio 18
JP - Giappone 17
ZA - Sudafrica 17
UZ - Uzbekistan 16
CO - Colombia 15
LT - Lituania 13
PK - Pakistan 13
PT - Portogallo 13
PH - Filippine 12
VE - Venezuela 12
CH - Svizzera 10
JM - Giamaica 8
KE - Kenya 8
NI - Nicaragua 7
PE - Perù 7
PY - Paraguay 7
SV - El Salvador 7
TW - Taiwan 7
EG - Egitto 6
GT - Guatemala 6
KZ - Kazakistan 6
AE - Emirati Arabi Uniti 5
JO - Giordania 5
NP - Nepal 5
PR - Porto Rico 5
RO - Romania 5
TN - Tunisia 5
BO - Bolivia 4
CR - Costa Rica 4
GR - Grecia 4
HN - Honduras 4
IL - Israele 4
IR - Iran 4
MA - Marocco 4
MY - Malesia 4
OM - Oman 4
AO - Angola 3
AZ - Azerbaigian 3
BG - Bulgaria 3
CL - Cile 3
CZ - Repubblica Ceca 3
GP - Guadalupe 3
NO - Norvegia 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
CI - Costa d'Avorio 2
DO - Repubblica Dominicana 2
EE - Estonia 2
EU - Europa 2
GD - Grenada 2
LB - Libano 2
LY - Libia 2
PA - Panama 2
QA - Qatar 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BT - Bhutan 1
BY - Bielorussia 1
DZ - Algeria 1
ET - Etiopia 1
GE - Georgia 1
HR - Croazia 1
KH - Cambogia 1
KW - Kuwait 1
LK - Sri Lanka 1
Totale 10.748
Salva come PNG Salva come JPEG
Città #
Ashburn 667
Ann Arbor 469
Singapore 448
San Jose 333
Hong Kong 281
Chandler 246
Fairfield 244
Dublin 224
Houston 213
Woodbridge 210
Milan 202
Frankfurt am Main 167
Wilmington 147
Toronto 137
Jacksonville 132
New York 131
Council Bluffs 110
Beijing 107
Seattle 97
Dearborn 94
Santa Clara 90
Ho Chi Minh City 83
Cambridge 74
Los Angeles 74
Chicago 71
Dallas 68
Rome 66
Princeton 64
The Dalles 59
Hefei 55
Nanjing 52
Hanoi 51
Lauterbourg 37
Moscow 35
Vienna 35
Seoul 34
São Paulo 32
Shanghai 31
Lawrence 27
Columbus 26
Orem 26
Buffalo 24
Barcelona 23
Boardman 23
Brooklyn 23
Guangzhou 23
Phoenix 23
San Diego 23
Chennai 22
Jakarta 21
Lachine 21
London 21
Naples 21
Munich 20
Helsinki 19
Altamura 18
Denver 18
Montreal 18
Andover 17
Shenyang 17
Warsaw 16
Brussels 15
Nanchang 15
Tashkent 15
Fremont 14
Quito 14
Stockholm 14
Tianjin 14
Bari 12
Florence 12
Guayaquil 12
Hangzhou 12
Philadelphia 12
Rio de Janeiro 12
Sesto San Giovanni 12
Boston 11
Dong Ket 11
Johannesburg 11
Lissone 11
Manchester 11
Nuremberg 11
Poplar 11
Turku 11
Norwalk 10
Salt Lake City 10
Tokyo 10
Atlanta 9
Baghdad 9
Brasília 9
Jinan 9
Newark 9
Padua 9
Riyadh 9
San Francisco 9
Allentown 8
Changsha 8
Jeddah 8
Lappeenranta 8
Nairobi 8
Perugia 8
Totale 6.583
Salva come PNG Salva come JPEG
Nome #
Infant ALL with MLL-AF4 is sustained by t(4;11) as the sole genetic abnormality, and it is initiated in mice by phenotypically and functionally distinct leukemic stem cell subsets 844
Preclinical Efficacy and Safety of CD19CAR Cytokine-Induced Killer Cells Transfected with Sleeping Beauty Transposon for the Treatment of Acute Lymphoblastic Leukemia 448
The histone deacetylase inhibitor givinostat (ITF2357) exhibits potent anti-tumor activity against CRLF2-rearranged BCP-ALL 415
Unravelling the cellular origin and clinical prognostic markers of infant B-cell acute lymphoblastic leukemia using genome-wide analysis 397
NG2 is a target gene of MLL-AF4 and underlies glucocorticoid resistance in MLL-r B-ALL by regulating NR3C1 expression 383
Antileukemic efficacy of BET inhibitor in a preclinical mouse model of MLL-AF4 + infant ALL 372
NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALL 371
PAX5 fusion genes are frequent in poor risk childhood acute lymphoblastic leukaemia and can be targeted with BIBF1120 342
Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse 340
Recurrent genetic fusions redefine MLL germ line acute lymphoblastic leukemia in infants 330
LCK over-expression drives STAT5 oncogenic signaling in PAX5 translocated BCP-ALL patients 305
Synergistic drug interactions of the histone deacetylase inhibitor givinostat (ITF2357) in CRLF2-rearranged pediatric B-cell precursor acute lymphoblastic leukemia identified by high-throughput drug screening 300
Clonal variegation and dynamic competition of leukemia-initiating cells in infant acute lymphoblastic leukemia with MLL rearrangement 294
Characterization of bortezomib-induced peripheral neuropathy in an immune-suppressed murine model 284
DNA copy-number abnormalities do not occur in infant ALL with t(4;11)/MLL-AF4 278
Effects of C/EBPalpha and C/EBPbeta in BCR/ABL-Expressing Cells: Differences and Similarities 271
Deciphering KRAS and NRAS mutated clone dynamics in MLL-AF4 paediatric leukaemia by ultra deep sequencing analysis 261
Development Refractoriness of MLL-Rearranged Human B Cell Acute Leukemias to Reprogramming into Pluripotency 257
Prenatal origin of NUTM1 gene rearrangement in infant B-cell precursor acute lymphoblastic leukaemia 249
In Infant ALL with t(4;11)/MLL-AF4 Multiple and Phenotypically Distinct CD19+ BM Subsets Initiate Leukemia in NOD/SCID Mice 239
The silent mutational landscape of infant MLL-AF4 pro-B acute lymphoblastic leukemia 239
Minimal residual disease in BCR::ABL1-positive acute lymphoblastic leukemia: different significance in typical ALL and in CML-like disease 238
Implementation of array based whole-genome high-resolution technologies confirms the absence of secondary copy-number alterations in MLL-AF4-positive infant ALL patients 233
Correction to: NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALL (Leukemia, (2018), 32, 3, (633-644), 10.1038/leu.2017.294) 225
The immune checkpoint ICOSLG is a relapse-predicting biomarker and therapeutic target in infant t(4;11) acute lymphoblastic leukemia 224
Generazione di modelli in vivo per l'identificazione e lo studio di clonalità delle cellule staminali leucemiche nella LAL infant MLL-AF4 positiva 222
Unique genomic profile of infant all patients 218
Expression of CCL9/MIP-1bold italic gamma is repressed by BCR/ABL and its restoration suppresses in vivo leukemogenesis of 32D-BCR/ABL cells 216
LAL infant introduces a new specific genomic profile 213
Infant ALL patients carrying t(4;11) have a different genotypic profile than older ALL children 210
Metabolic adaptation of acute lymphoblastic leukemia to the central nervous system microenvironment is dependent on Stearoyl CoA desaturase 209
Identification and characterization of candidate L-ICs IN MLL-AF4 infant all 208
In infant all with t(4;11)/mll-af4 multiple and phenotypically distinct bm subsets initiate leukemia into nod/scid mice 207
Infant ALL patients carrying t(4;11) have a different genotypic profile than older ALL children 204
Infant ALL patients carrying t(4;11) have a different genotypic profile than older ALL children 201
Oligoclonal origin of functionally distinct leukemic stem cells in infant acute lymphoblastic leukemia 200
Inducible activation of C/EBPb, a gene negatively regulated by BCR/ABL, inhibits proliferation and promotes differentiation of BCR/ABL-expressing cells 196
Distinct pattern of genomic breakpoints in CML and BCR::ABL1-positive ALL: analysis of 971 patients 185
The EGR3 regulome of infant KMT2A-r acute lymphoblastic leukemia identifies differential expression of B-lineage genes predictive for outcome 140
Totale 10.968
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.264
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.264
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022338 0 0 0 30 42 68 14 24 19 46 20 75
2022/2023920 86 275 86 74 51 155 14 55 76 1 35 12
2023/2024660 26 30 41 35 75 178 122 31 44 14 20 44
2024/20251.480 79 120 65 90 93 39 110 35 172 266 141 270
2025/20263.749 438 195 311 468 430 190 418 187 251 361 264 236
2026/20271.142 129 131 385 497 0 0 0 0 0 0 0 0
Totale 10.968